Correlates of toxicity in metastatic melanoma patients treated with ipilimumab.

被引：0
|
作者：
Valpione, Sara
Pigozzo, Jacopo
Pasquali, Sandro
Piccin, Luisa
Mocellin, Simone
Campana, Luca Giovanni
Chiarion-Sileni, Vanna
机构：
[1] Univ Padua, Padua, Italy
[2] Ist Oncol Veneto IRCCS, Padua, Italy
[3] Univ Naples Federico II, Padua, Italy
[4] Univ Padua, Dept Oncol & Surg Sci, Padua, Italy
[5] Veneto Oncol Inst, Padua, Italy
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2016年 / 34卷 / 15期
关键词：
D O I：
10.1200/JCO.2016.34.15_suppl.e21010
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e21010
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Real-world efficacy and toxicity of combined nivolumab and ipilimumab in patients with metastatic melanoma
    Parakh, Sagun
    Randhawa, Manreet
    Nguyen, Bella
    Warburton, Lydia
    Hussain, Mohammad Akhtar
    Cebon, Jonathan
    Millward, Michael
    Yip, Desmond
    Ali, Sayed
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2019, 15 (01) : 26 - 30
  • [32] The impact of body composition parameters on ipilimumab toxicity in metastatic melanoma
    Daly, L.
    O'Reilly, A.
    Donnelan, P.
    Cushen, S.
    Woodlock, D.
    Power, D. G.
    Ryan, A. M.
    PROCEEDINGS OF THE NUTRITION SOCIETY, 2015, 74 (OCE4) : E270 - E270
  • [33] Immune cell profiling of melanoma metastases from patients treated with TriMixDC-MEL dendritic cell therapy in combination with ipilimumab.
    Schats, Kelly
    Van Vre, Emily A.
    Debyser, Isolde
    Vandenbroeck, Arno
    Jansen, Yanina
    Seremet, Teofila
    Marien, Koen
    Fransen, Erik
    Schrijvers, Dorien
    Van Criekinge, Wim
    Thielemans, Kris
    Neyns, Bart
    De Meester, Ingrid
    Kockx, Mark
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [34] Immunological correlates of treatment and response in stage IV malignant melanoma patients treated with Ipilimumab
    Bjoern, Jon
    Nitschke, Nikolaj Juul
    Iversen, Trine Zeeberg
    Schmidt, Henrik
    Fode, Kirsten
    Svane, Inge Marie
    ONCOIMMUNOLOGY, 2016, 5 (04):
  • [35] Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
    Hodi, F. Stephen
    O'Day, Steven J.
    McDermott, David F.
    Weber, Robert W.
    Sosman, Jeffrey A.
    Haanen, John B.
    Gonzalez, Rene
    Robert, Caroline
    Schadendorf, Dirk
    Hassel, Jessica C.
    Akerley, Wallace
    van den Eertwegh, Alfons J. M.
    Lutzky, Jose
    Lorigan, Paul
    Vaubel, Julia M.
    Linette, Gerald P.
    Hogg, David
    Ottensmeier, Christian H.
    Lebbe, Celeste
    Peschel, Christian
    Quirt, Ian
    Clark, Joseph I.
    Wolchok, Jedd D.
    Weber, Jeffrey S.
    Tian, Jason
    Yellin, Michael J.
    Nichol, Geoffrey M.
    Hoos, Axel
    Urba, Walter J.
    NEW ENGLAND JOURNAL OF MEDICINE, 2010, 363 (08): : 711 - 723
  • [36] Ipilimumab improves survival in metastatic melanoma patients
    Hodi, F. S.
    O'Day, S. J.
    McDermott, D. F.
    IMMUNOTHERAPY, 2011, 3 (08) : 928 - 929
  • [37] Bevacizumab plus Ipilimumab in Patients with Metastatic Melanoma
    Hodi, F. Stephen
    Lawrence, Donald
    Lezcano, Cecilia
    Wu, Xinqi
    Zhou, Jun
    Sasada, Tetsuro
    Zeng, Wanyong
    Giobbie-Hurder, Anita
    Atkins, Michael B.
    Ibrahim, Nageatte
    Friedlander, Philip
    Flaherty, Keith T.
    Murphy, George F.
    Rodig, Scott
    Velazquez, Elsa F.
    Mihm, Martin C., Jr.
    Russell, Sara
    DiPiro, Pamela J.
    Yap, Jeffrey T.
    Ramaiya, Nikhil
    van den Abbeele, Annick D.
    Gargano, Maria
    McDermott, David
    CANCER IMMUNOLOGY RESEARCH, 2014, 2 (07) : 632 - 642
  • [38] IPILIMUMAB FOR METASTATIC MELANOMA
    Ozao-Choy, J.
    Carvajal, R. D.
    Hamid, O.
    DRUGS OF TODAY, 2012, 48 (06) : 381 - 393
  • [39] Metastatic Melanoma and Ipilimumab
    不详
    JOURNAL OF DRUGS IN DERMATOLOGY, 2009, 8 (08) : 777 - 777
  • [40] A systematic evaluation of abscopal responses following radiotherapy in patients with metastatic melanoma treated with ipilimumab
    Chandra, Ravi A.
    Wilhite, Tyler J.
    Balboni, Tracy A.
    Alexander, Brian M.
    Spektor, Alexander
    Ott, Patrick A.
    Ng, Andrea K.
    Hodi, F. Stephen
    Schoenfeld, Jonathan D.
    ONCOIMMUNOLOGY, 2015, 4 (11):
12345